Scarica l'app Stockscreener
19.05
8.86%
1.55
Dopo l'orario di chiusura:
19.39
0.34
+1.78%
Precedente Chiudi:
$17.50
Aprire:
$17.58
Volume 24 ore:
539.84K
Relative Volume:
3.57
Capitalizzazione di mercato:
$233.46M
Reddito:
$1.54M
Utile/perdita netta:
$-38.70M
Rapporto P/E:
-4.0792
EPS:
-4.67
Flusso di cassa netto:
$-36.86M
1 W Prestazione:
+21.34%
1M Prestazione:
+85.49%
6M Prestazione:
+221.79%
1 anno Prestazione:
-0.42%
Intervallo 1D:
$17.14
$19.06
Intervallo di 1 settimana:
$15.00
$19.06
Portata 52W:
$4.64
$20.77
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
Nome
Corbus Pharmaceuticals Holdings Inc
Settore
Industria
Telefono
617-963-0103
Indirizzo
500 RIVER RIDGE DRIVE, NORWOOD, MA
Confronta CRBP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRBP
Corbus Pharmaceuticals Holdings Inc
|
19.05 | 199.15M | 1.54M | -38.70M | -36.86M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-30 | Ripresa | B. Riley Securities | Buy |
| 2025-02-28 | Iniziato | William Blair | Outperform |
| 2024-12-02 | Iniziato | Piper Sandler | Overweight |
| 2024-07-30 | Iniziato | Wedbush | Outperform |
| 2024-07-22 | Ripresa | H.C. Wainwright | Buy |
| 2024-06-26 | Iniziato | B. Riley Securities | Buy |
| 2024-06-03 | Reiterato | Oppenheimer | Outperform |
| 2024-05-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-03-06 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-08 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-09-08 | Downgrade | Jefferies | Buy → Hold |
| 2020-09-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-08 | Downgrade | ROTH Capital | Buy → Neutral |
| 2020-07-07 | Iniziato | ROTH Capital | Buy |
| 2020-06-17 | Iniziato | BTIG Research | Buy |
| 2020-03-26 | Iniziato | Nomura | Buy |
| 2019-04-05 | Iniziato | Jefferies | Buy |
| 2019-03-20 | Iniziato | Oppenheimer | Outperform |
| 2019-01-11 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-12-26 | Iniziato | H.C. Wainwright | Buy |
| 2018-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2018-10-24 | Iniziato | B. Riley FBR | Buy |
| 2018-01-19 | Iniziato | Raymond James | Outperform |
| 2017-12-14 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-11-08 | Reiterato | Noble Financial | Buy |
| 2017-09-29 | Ripresa | Noble Financial | Buy |
| 2017-03-30 | Reiterato | Cantor Fitzgerald | Overweight |
| 2016-11-15 | Reiterato | JMP Securities | Mkt Outperform |
| 2016-11-11 | Reiterato | Noble Financial | Buy |
Mostra tutto
Corbus Pharmaceuticals Holdings Inc Borsa (CRBP) Ultime notizie
Why Corbus Pharmaceuticals Holdings Inc. stock is favored by pension fundsTrend Reversal & Entry and Exit Point Strategies - newser.com
How sentiment analysis helps forecast Corbus Pharmaceuticals Holdings Inc.GDP Growth & Safe Entry Trade Reports - newser.com
Visual analytics tools that track Corbus Pharmaceuticals Holdings Inc. performanceTrade Ideas & Safe Swing Trade Setup Alerts - newser.com
Can Corbus Pharmaceuticals Holdings Inc. (3371) stock deliver strong annual returnsJuly 2025 Weekly Recap & Free Daily Entry Point Trade Alerts - newser.com
Corbus Pharmaceuticals (CRBP) to Showcase Updated Clinical Data at ESMO 2025 - GuruFocus
Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025 - GlobeNewswire
Can Corbus Pharmaceuticals Holdings Inc. stock maintain operating marginsQuarterly Performance Summary & Daily Chart Pattern Signals - newser.com
How hedge fund analytics apply to Corbus Pharmaceuticals Holdings Inc. stockJuly 2025 Catalysts & Free Safe Entry Trade Signal Reports - newser.com
Best data tools to analyze Corbus Pharmaceuticals Holdings Inc. stockMarket Growth Summary & Precise Swing Trade Alerts - newser.com
CRBP stock touches 52-week low at $9.26 amid market challenges - MSN
How Corbus Pharmaceuticals Holdings Inc. (3371) stock valuation compares with sectorTrade Performance Summary & Community Verified Watchlist Alerts - newser.com
Can swing trading help recover from Corbus Pharmaceuticals Holdings Inc. lossesMarket Trend Report & Reliable Entry Point Alerts - newser.com
How to build a dashboard for Corbus Pharmaceuticals Holdings Inc. stockDay Trade & Weekly Market Pulse Updates - newser.com
What analysts say about Corbus Pharmaceuticals Holdings Inc 3371 stockBull Market Opportunities & Free Real-Time Trading Signals - earlytimes.in
Is Corbus Pharmaceuticals Holdings Inc. reversing from oversold territoryTake Profit & Long-Term Capital Growth Strategies - newser.com
Can Corbus Pharmaceuticals Holdings Inc. hit a new high this monthAnalyst Upgrade & Proven Capital Preservation Methods - newser.com
Is a relief rally coming for Corbus Pharmaceuticals Holdings Inc. holdersQuarterly Growth Report & Verified Short-Term Trading Plans - newser.com
Is Corbus Pharmaceuticals Holdings Inc. stock reversal real or fakeJuly 2025 Breakouts & Expert Verified Stock Movement Alerts - newser.com
Corbus Pharmaceuticals' (CRBP) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
After-Hours Surge: Turn Therapeutics Rockets 134% Post-Close On Nasdaq Debut; Biotech Stocks Rally - RTTNews
Corbus Pharmaceuticals to Participate in the Upcoming Piper Sandler Virtual Oncology Symposium - GlobeNewswire
Oct 9 Fireside Chat 10:00AM ET — Corbus CEO Yuval Cohen to Present at Piper Sandler Virtual Oncology Symposium - Stock Titan
What analysts say about Corbus Pharmaceuticals Holdings Inc stockMarket Capitalization Trends & Affordable Trading Growth - earlytimes.in
Corbus Pharmaceuticals Holdings Inc. stock outlook for YEARAnalyst Upgrade & Safe Entry Zone Tips - newser.com
Published on: 2025-10-05 06:30:04 - newser.com
Is Corbus Pharmaceuticals Holdings Inc. stock gaining market share2025 Risk Factors & Free Long-Term Investment Growth Plans - newser.com
Published on: 2025-10-05 03:14:17 - newser.com
Published on: 2025-10-05 02:56:16 - newser.com
Institutional scanner results for Corbus Pharmaceuticals Holdings Inc.Portfolio Value Summary & Growth Focused Stock Pick Reports - newser.com
These Are The 3 Top-Rated Cannabis Stocks To Buy As Trump Backs CBD - Barchart.com
Oppenheimer lowers Corbus Pharmaceuticals stock price target ahead of ESMO data - Investing.com Canada
What drives Corbus Pharmaceuticals Holdings Inc 3371 stock priceTrade Execution Strategies & Exceptional Growth Investment - earlytimes.in
Corbus Pharmaceuticals (NASDAQ:CRBP) Shares Cross Above 50-Day Moving AverageTime to Sell? - MarketBeat
Published on: 2025-09-29 15:28:09 - newser.com
Corbus Pharmaceuticals Holdings Inc Azioni (CRBP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Corbus Pharmaceuticals Holdings Inc Azioni (CRBP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Altmeyer Anne | Director |
May 30 '25 |
Sale |
7.25 |
1,392 |
10,096 |
1,391 |
| Smethurst Dominic | Chief Medical Officer |
Mar 06 '25 |
Sale |
6.78 |
6,393 |
43,330 |
70,807 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):